#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Colon cancer Glomerulonephritis membranous Mastocytosis Endometrial cancer Infantile apnoea Univentricular heart Osteopetrosis Central nervous system neoplasm Hypomagnesaemia Insulinoma Metabolic disorder Stevens-Johnson syndrome Demyelination Proteus syndrome Frostbite More trials…

    Learn about Rare Diseases

    Choroid melanoma – Diagnostics Toxic epidermal necrolysis – Diagnostics Basal cell naevus syndrome – Basic Information Hereditary angioedema Marfan’s syndrome – Life with Disease Langerhans cell sarcoma – Life with Disease Gaucher’s disease type I Haemophagocytic lymphohistiocytosis – Diagnostics Carcinoid syndrome – Trials in Disease Osteosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fenofibrate Micronised Vatiquinone Ammonium Chloride Bp Baricitinib Ranolazine Ucart22 Eclitasertib Axitinib Modafinil Difelikefalin Avibactam Sodium Sirolimus Flecainide GSKVX000000070965 Ly3819469 Sodium Highly Refined Fish Oil Erlotinib Cellulose, Microcrystalline Prednisolone Azd5004 More therapies…

    Learn about Your Condition

    Emphysema Traumatic pain Overweight Urinary tract infection Cancer pain Osteonecrosis of jaw Thymoma malignant Neuroblastoma Acute hepatic failure Leukaemia Haemorrhage prophylaxis Postpartum haemorrhage Hip arthroplasty Hepatic neoplasm Rabies More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • 1-{6-[(4M)-4-(5-Chloro-6-Methyl-1H -Indazol-4-Yl)-5-Methyl-3-(1-Methyl-1H -Indazol-5-Yl)-1H -Pyrazol-1-Yl]-2-Azaspiro[3.3]Heptan-2-Yl}Prop-2-En-1-One
    Austria Belgium France Germany Greece Hungary +4

  • Efficacy of Cobolimab, Dostarlimab, and Docetaxel in Advanced Non-Small Cell Lung Cancer Post Anti-PD(L)1 Therapy and Chemotherapy

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cobolimab
    • Docetaxel
    • Dostarlimab
    Belgium Finland France Germany Greece Italy +5

  • A study to evaluate how the body processes zipalertinib in healthy adult men

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • [14C]ZIPALERTINIB
    The Netherlands

  • A study to evaluate how lazertinib is absorbed in healthy adults to support future treatment for non-small cell lung cancer.

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Lazertinib
    Belgium

  • A Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Cldn6 Car-T
    • Cldn6 Car-T(A)
    • Cldn6 Rna-Lpx
    Germany The Netherlands Sweden

  • Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer
    • Breast cancer
    • Thrombocytopenia
    Investigated Drugs:
    • Romiplostim
    Greece Poland Portugal Romania Spain
Previous Page
1 … 22 23 24 25 26 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!